The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
NF-κB activation as a pathological mechanism of septic shock and inflammation
Abstract
The pathophysiology of sepsis and septic shock involves complex cytokine and inflammatory mediator networks. NF-κB activation is a central event leading to the activation of these networks. The role of NF-κB in septic pathophysiology and the signal transduction pathways leading to NF-κB activation during sepsis have been an area of intensive investigation. NF-κB is activated by a variety of pathogens known to cause septic shock syndrome. NF-κB activity is markedly increased in every organ studied, both in animal models of septic shock and in human subjects with sepsis. Greater levels of NF-κB activity are associated with a higher rate of mortality and worse clinical outcome. NF-κB mediates the transcription of exceptional large number of genes, the products of which are known to play important roles in septic pathophysiology. Mice deficient in those NF-κB-dependent genes are resistant to the development of septic shock and to septic lethality. More importantly, blockade of NF-κB pathway corrects septic abnormalities. Inhibition of NF-κB activation restores systemic hypotension, ameliorates septic myocardial dysfunction and vascular derangement, inhibits multiple proinflammatory gene expression, diminishes intravascular coagulation, reduces tissue neutrophil influx, and prevents microvascular endothelial leakage. Inhibition of NF-κB activation prevents multiple organ injury and improves survival in rodent models of septic shock. Thus NF-κB activation plays a central role in the pathophysiology of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Waris, G., Livolsi, A., Imbert, V., Peyron, J., & Siddiqui, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303248200 · Cited by 118
RetractedEfficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 27×
“Binding of IB to NF-B dimers masks the NLS of one NF-B subunit with the NLS on the other subunit being exposed (169).”
Influential
Research works printed but not linked: 20
- 10.1074/jbc.M211831200 · doi:10.1074/jbc.m211831200
- 10.1016/S0041-1345(01)02521-0 · doi:10.1016/s0041-1345(01)02521-0
- 10.1074/jbc.M201576200 · doi:10.1074/jbc.m201576200
- 10.1152/ajpheart.00394.2001 · DOI
- 10.1124/mol.64.6.1541 · doi:10.1124/mol.64.6.1541
- 10.1152/ajpheart.2001.280.4.H1464 · doi:10.1152/ajpheart.2001.280.4.h1464
- 10.1002/(SICI)1521-4141(199906)29:06<1890::AID-IMMU1890>3.0.CO;2-F · doi:10.1002/(sici)1521-4141(199906)29:06<1890::aid-immu1890>3.0.co;2-f
- 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1 · doi:10.1002/(sici)1097-4644(199701)64:1<27::aid-jcb5>3.0.co;2-1
- 10.1074/jbc.M207515200 · doi:10.1074/jbc.m207515200
- 10.1016/j.ejcts.2004.09.016 · doi:10.1016/j.ejcts.2004.09.016
- 10.1016/S0076-6879(02)59191-6 · doi:10.1016/s0076-6879(02)59191-6
- 10.1097/00024382-200014020-00007 · doi:10.1097/00024382-200014020-00007
- 10.1152/ajpregu.00034.2002 · doi:10.1152/ajpregu.00034.2002
- 10.1172/JCI200319523 · DOI
- 10.1093/infdis/172.4.1001 · doi:10.1093/infdis/172.4.1001
- 10.4049/jimmunol.172.2.1054 · DOI
- 10.1152/ajpheart.1998.275.3.H1084 · DOI
- 10.1124/mol.61.5.953 · doi:10.1124/mol.61.5.953
- 10.1177/09680519020080020301 · doi:10.1177/09680519020080020301
- 10.1067/mtc.2001.115917 · doi:10.1067/mtc.2001.115917
Cited by
He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., Li, X., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176356 · Cited by 1,064
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Mechanisms and treatment of organ failure in sepsis
Lelubre, C., & Vincent, J.-L. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0005-7 · Cited by 852
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 614
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors
Brigelius-Flohé, R., & Flohé, L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3534 · Cited by 576
Gram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433
Regulation of short-chain fatty acids in the immune system
Liu, X.-F., Shao, J.-H., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-J., Liu, Z.-Z., He, D.-D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 403
Hossain, M. S., Urbi, Z., Sule, A., & Rahman, K. M. H. (2014) · The Scientific World Journal · doi:10.1155/2014/274905 · Cited by 341
Kim, S.-R., Bae, Y.-H., Bae, S.-K., Choi, K.-S., Yoon, K.-H., Koo, T. H., Jang, H.-O., Yun, I., Kim, K.-W., Kwon, Y.-G., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.004 · Cited by 316
Gitto, E., Pellegrino, S., Gitto, P., Barberi, I., & Reiter, R. J. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00649.x · Cited by 291
Recognition of lipid A variants by the TLR4-MD-2 receptor complex
Maeshima, N., & Fernandez, R. C. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00003 · Cited by 280
Kim, J.-Y., Park, S. J., Yun, K.-J., Cho, Y.-W., Park, H.-J., & Lee, K.-T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.032 · Cited by 265
Peroxisome Proliferator-Activated Receptor-γ–Mediated Effects in the Vasculature
Duan, S. Z., Usher, M. G., & Mortensen, R. M. (2008) · Circulation Research · doi:10.1161/circresaha.107.164384 · Cited by 263
Regulators of endothelial and epithelial barrier integrity and function in acute lung injury
Lucas, R., Verin, A. D., Black, S. M., & Catravas, J. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.014 · Cited by 263
Activation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis
Castellheim, A., Brekke, O. ‐., Espevik, T., Harboe, M., & Mollnes, T. E. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02255.x · Cited by 257
Zhang, W.-J., Wei, H., Hagen, T., & Frei, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700305104 · Cited by 257
Selkirk, G. A., McLellan, T. M., Wright, H. E., & Rhind, S. G. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00917.2007 · Cited by 170
Antonov, A. S., Antonova, G. N., Munn, D. H., Mivechi, N., Lucas, R., Catravas, J. D., & Verin, A. D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22356 · Cited by 128
“The signaling pathways and the mechanisms of NF-kB activation/ deactivation are well established for many cell types including macrophages (Liu and Malik, 2006).”
BackgroundYamada, H., Yoshida, M., Nakano, Y., Suganami, T., Satoh, N., Mita, T., Azuma, K., Itoh, M., Yamamoto, Y., Kamei, Y., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171736 · Cited by 112
Ibrahim, Y. F., Moussa, R. A., Bayoumi, A. M. A., & Ahmed, A.-S. F. (2020) · Inflammopharmacology · doi:10.1007/s10787-019-00628-y · Cited by 75
Serum amyloid A1 mediates myotube atrophy via Toll‐like receptors
Hahn, A., Kny, M., Pablo‐Tortola, C., Todiras, M., Willenbrock, M., Schmidt, S., Schmoeckel, K., Jorde, I., Nowak, M., Jarosch, E., et al. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12491 · Cited by 67
Kamiyama, K., Matsuda, N., Yamamoto, S., Takano, K.-I., Takano, Y., Yamazaki, H., Kageyama, S.-I., Yokoo, H., Nagata, T., Hatakeyama, N., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2007 · Cited by 53
“NF- B is a proinflammatory transcription factor, and its activation is a central molecular event leading to the development of septic shock and inflammation (30).”
Dusabimana, T., Je, J., Yun, S. P., Kim, H. J., Kim, H., & Park, S. W. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05975-x · Cited by 45
Nguyen, M., Gautier, T., Masson, D., Bouhemad, B., & Guinot, P.-G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072579 · Cited by 25
“More specifically, after TLR-4 activation, LPS activate pro-inflammatory pathways, resulting in endothelial dysfunction, coagulopathy, and cardiovascular dysfunction [10,11].”
Background
Metadata
- Authors
- Liu, S. F., & Malik, A. B.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2006-04
- Volume
- 290
- Issue
- 4
- Pages
- L622-L645
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W1999325378
- Cited by
- 761
- References
- 260
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.